Editorial Team
The management of our journal is a collaborative endeavor by the whole editorial team, featuring an active, widely respected, diverse, and representative Editorial Board. The editorial structure of the journal is listed as below and the roles and responsibilities of the editorial team are available at: https://www.amegroups.com/pages/journal-management#content-title.
Honorary Editor-in-Chief
Fred R. Hirsch, MD, PhD
Executive Director, Center for Thoracic Oncology, Tisch Cancer Institute at Mount Sinai, New York, NY, USA
Editors-in-Chief
Yong Song, MD, PhD
Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China
Caicun Zhou, MD, PhD
Department of Oncology, Shanghai Pulmonary Hospital, Affiliated to Tongji University School of Medicine, Shanghai, China
Rafael Rosell, MD, PhD
Chief Medical Officer and President, IOR, Dr. Rosell Oncology Institute
Dexeus University Hospital, Barcelona, Spain
Associate Editors-in-Chief
Sai-Hong Ignatius Ou, MD, PhD
Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, CA, USA
Wenhua Liang, MD (Oncology)
Thoracic oncology, the First Affiliated Hospital of Guangzhou Medical University, China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, China
Jessica J. Lin, MD
Assistant Professor of Medicine, Harvard Medical School, Boston, USA
Editorial Board
Julie R. Brahmer, MD, MSc, FASCO
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Alberto D'Angelo, MD, PhD, MSc, BSc
Department of Biology & Biochemistry, University of Bath, UK
Ramon Andrade De Mello
Medical Oncology, Nine of July University (UNINOVE), São Paulo, Brazil
Kai Ding, PhD, MBA, DABR
Department of Radiation Oncology and Molecular Radiation Sciences and Carnegie Center of Surgical Innovation, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Kwun M. Fong, MBBS(Lon), FRACP, PhD
Department of Thoracic Medicine, The Prince Charles Hospital; Professor, School of Medicine, The University of Queensland, Brisbane, Australia
Muhammad Furqan
Department of Internal Medicine, Section of Solid Tumor Oncology, University of Oklahoma, Oklahoma City, OK, USA
Gerhard Hamilton, PhD
Department of Surgery, Research Lab, Medical University of Vienna, Vienna, Austria
Toyoaki Hida, MD, PhD
Lung Cancer Center, Central Japan International Medical Center, Minokamo, Japan
Farhad Islami
Surveillance and Health Equity Research, American Cancer Society, Atlanta, USA
Jacek Jassem, MD, PhD, Dr h.c.
Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland
Shuben Li, MD, PhD
Department of Thoracic Surgery, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, Guangdong, China
Steven H. Lin, MD, PhD
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Texas, USA
Stephen V. Liu
Department of Medicine, Division of Medical Oncology, Georgetown University, Washington, DC, USA
Hongxu Liu, MD
Department of Thoracic Surgery, Liaoning Cancer Hospital & Institute, Shenyang, China
Fernando Lopez-Rios, MD, PhD
Pathology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Research Institute Hospital 12 de Octubre (i+12), CIBERONC, Madrid, Spain.
Alexander V. Louie
Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
Mari Mino-Kenudson, MD
Department of Pathology, Massachusetts General Hospital, Boston, MA, USA
Luis M. Montuenga, PhD
LUNGSEARCH, Lung cancer Screening, early detection, biomarkers and new therapeutic targets laboratory. Solid Tumors Program, Centro de Investigación Médica Aplicada (CIMA), Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain; Navarra Institute for Health Research, Pamplona, Spain; CIBERONC, Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain
Sujie Ni, MD, PhD
Department of Medical Oncology, Affiliate Hospital of Nantong University, Jiangsu, China
Yusuke Okuma, MD, PhD
Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan
Chang Min Park
Department of Radiology, Seoul National University Hospital, Seoul, Korea
Robert Pirker
Medical University of Vienna, Vienna, Austria
Mariano Provencio, MD, PhD
Department of Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
Robert Ramirez, DO, FACP
Associate Professor of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA
Laila C. Roisman, PhD
Director of the Precision Oncology and Innovation Unit, Shaare Zedek Medical Center, Jerusalem, Israel
Jaime L. Schneider, MD, PhD
Division of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Harvard Medical School, Boston, MA, USA
Charles B. Simone II, MD, FASTRO, FACRO
New York Proton Center, New York, NY, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA
Matthew P. Smeltzer, PhD, MStat
Associate Professor of Epidemiology and Biostatistics and University Research Professor at the University of Memphis School of Public Health, Memphis, TN, USA
Ming-Sound Tsao, MD, FRCPC
Princess Margaret Cancer Centre, University Health Network and Department of Medical Biophysics, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
Hironori Uruga
Departments of Pathology and Respiratory Medicine, Toranomon Hospital, Tokyo, Japan
Paul A. VanderLaan, MD, PhD
Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
Everett E. Vokes
John E. Ultmann Distinguished Service Professor; Chair, Department of Medicine, Section of Hematology/Oncology, Comprehensive Cancer Center, University of Chicago, 5841 S Maryland Ave, MC 6092, Chicago, IL 60637, USA
Tadaaki Yamada, MD, PhD
Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
Sai Yendamuri, MD, FACS
Department of Thoracic Surgery, Roswell Park Cancer Institute, Buffalo, New York;
Department of Surgery, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA
Jianjun Zhang
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center UTHealth Houston, Houston, TX 77030, USA; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Lung Cancer Genomics Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Lung Cancer Interception Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Managing Editors
Grace S. Li
Editorial Office, Translational Lung Cancer Research, AME Publishing Company
Eunice X. Xu
Editorial Office, Translational Lung Cancer Research, AME Publishing Company
Senior Editors
Skylar F. Gao
Editorial Office, Translational Lung Cancer Research, AME Publishing Company
Anne X. Lu
Editorial Office, Translational Lung Cancer Research, AME Publishing Company
Silvia L. Zhou
Editorial Office, Translational Lung Cancer Research, AME Publishing Company
Corresponding Editor
Mira Wu
Editorial Office, Translational Lung Cancer Research, AME Publishing Company
Science Editors
Aisling Luo
Editorial Office, Translational Lung Cancer Research, AME Publishing Company
Brad Li
Editorial Office, Translational Lung Cancer Research, AME Publishing Company
Hailing Lian
Editorial Office, Translational Lung Cancer Research, AME Publishing Company
Xing Liu
Editorial Office, Translational Lung Cancer Research, AME Publishing Company
